Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania.
J Surg Res. 2014 Aug;190(2):471-7. doi: 10.1016/j.jss.2014.05.039. Epub 2014 May 22.
The model for end-stage liver disease (MELD) has been validated as a prediction tool for postoperative mortality, but its role in predicting morbidity has not been well studied. We sought to determine the role of MELD, among other factors, in predicting morbidity and mortality in patients with nonmalignant ascites undergoing hernia repair.
All patients undergoing hernia repair in the American College of Surgeons National Surgical Quality Improvement database (2009-11) were identified. Those with nonmalignant ascites were compared with patients without ascites. A subset analysis of patients with nonmalignant ascites was performed to evaluate the association between MELD and morbidity and mortality with adjustment for potential confounders. The association of significant factors with the rate of morbidity was displayed using a best-fit polynomial regression.
Of 138,366 hernia repairs, 778 (0.56%) were performed on patients with nonmalignant ascites. Thirty-day morbidity (4% versus 19%) and mortality (0.2% versus 5.3%) were significantly more frequent in patients with ascites (P < 0.001). In univariate analysis of the 636 patients with a calculable MELD, MELD was associated with both morbidity and mortality (P < 0.001 each). In multivariate analysis, MELD remained significantly associated with morbidity (odds ratio [OR] = 1.11). Ventral hernia repair (OR = 2.9), dependent functional status (OR = 2.3), alcohol use (OR = 2.3), emergent operation (OR = 2.0) white blood count (OR = 1.1), and age (OR = 1.02) were also significantly associated with morbidity (P < 0.05).
Before hernia repair, the MELD score can be used to risk-stratify patients with nonmalignant ascites not only for mortality but also morbidity. Morbidity rates increase rapidly with MELD above 15, but other factors should additionally be accounted for when counseling patients on their perioperative risk.
终末期肝病模型(MELD)已被验证为预测术后死亡率的工具,但它在预测发病率方面的作用尚未得到充分研究。我们旨在确定 MELD 与其他因素在预测非恶性腹水患者疝修补术后发病率和死亡率中的作用。
在美国外科医师学会国家手术质量改进数据库(2009-11 年)中确定所有接受疝修补术的患者。将有非恶性腹水的患者与没有腹水的患者进行比较。对有非恶性腹水的患者进行亚组分析,以评估 MELD 与发病率和死亡率的关联,并对潜在混杂因素进行调整。使用最佳拟合多项式回归显示显著因素与发病率之间的关联。
在 138366 例疝修补术中,有 778 例(0.56%)在有非恶性腹水的患者中进行。有腹水的患者 30 天发病率(4%比 19%)和死亡率(0.2%比 5.3%)显著更高(P<0.001)。在可计算 MELD 的 636 例患者的单因素分析中,MELD 与发病率和死亡率均相关(均 P<0.001)。在多因素分析中,MELD 与发病率仍显著相关(比值比[OR] = 1.11)。腹疝修补术(OR = 2.9)、依赖功能状态(OR = 2.3)、酒精使用(OR = 2.3)、急诊手术(OR = 2.0)、白细胞计数(OR = 1.1)和年龄(OR = 1.02)也与发病率显著相关(P<0.05)。
在疝修补术前,MELD 评分不仅可以用于预测非恶性腹水患者的死亡率,还可以用于预测发病率。MELD 超过 15 分后,发病率迅速增加,但在向患者提供围手术期风险咨询时,还应考虑其他因素。